RECRUITING

Predictors of Behavioral Obesity Treatment Outcomes

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Socioceconomically disadvantaged individuals typically have poor outcomes in behavioral weight loss interventions, but the reasons for this are unknown. This project will characterize the mechanisms through which adverse daily experiences and present bias -- a cognitive adaptation to harsh and unpredictable environments -- account for disparities in weight loss outcomes.

Official Title

Predictors of Behavioral Obesity Treatment Outcomes

Quick Facts

Study Start:2023-05-26
Study Completion:2028-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05326477

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age ≥18 years old
  2. 2. Obesity (body mass index ≥30 kg/m2)
  3. 3. Meets criteria for either the lower SES or higher SES cohort
  1. 1. Not fluent in English
  2. 2. Change in income or financial assets exceeding ±75% of federal poverty guideline within the past 12 months, or expected in the next 6 months, if this change would result in reclassification on SES.
  3. 3. Previous or planned bariatric surgery, or concurrent engagement in other behavioral or pharmacological treatment for obesity
  4. 4. Resides more than 20 miles away from Rush, or planning to move outside of this geographic area during the study period
  5. 5. Body mass index ≥60 kg/m2, due to increased injury risk with exercise
  6. 6. History of bariatric surgery, or current engagement in another weight loss therapy
  7. 7. Lack of reliable access to cell or landline phone
  8. 8. Medical contraindications to treatment, including osteoporosis, cognitive impairment (Montreal Cognitive Assessment ≤25), active substance abuse based on the World Health Organization's ASSIST screener, lack of physician clearance for participation, or serious medical illness (e.g., stage 3 or 4 heart failure, cancer, renal failure, etc.)

Contacts and Locations

Study Contact

Bradley M Appelhans, PHD
CONTACT
312-942-3477
brad_appelhans@rush.edu

Study Locations (Sites)

Rush University Medical Center
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: Rush University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-26
Study Completion Date2028-06-30

Study Record Updates

Study Start Date2023-05-26
Study Completion Date2028-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Obesity